FI946128A0 - Biologisesti aktiiviset yhdisteet - Google Patents

Biologisesti aktiiviset yhdisteet

Info

Publication number
FI946128A0
FI946128A0 FI946128A FI946128A FI946128A0 FI 946128 A0 FI946128 A0 FI 946128A0 FI 946128 A FI946128 A FI 946128A FI 946128 A FI946128 A FI 946128A FI 946128 A0 FI946128 A0 FI 946128A0
Authority
FI
Finland
Prior art keywords
pct
mol
image
residue
sec
Prior art date
Application number
FI946128A
Other languages
English (en)
Swedish (sv)
Other versions
FI946128A (fi
FI112602B (fi
Inventor
Francesco Angelucci
Maria Grandi
Antonino Suarato
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI946128A publication Critical patent/FI946128A/fi
Publication of FI946128A0 publication Critical patent/FI946128A0/fi
Application granted granted Critical
Publication of FI112602B publication Critical patent/FI112602B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polyamides (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FI946128A 1993-05-11 1994-12-28 Menetelmä biologisesti aktiivisten polymeerisitoutuneiden antrasykliinien valmistamiseksi FI112602B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939309663A GB9309663D0 (en) 1993-05-11 1993-05-11 Biologically active compounds
GB9309663 1993-05-11
PCT/EP1994/001100 WO1994026311A1 (en) 1993-05-11 1994-04-08 Anthracycline conjugates, their preparation and their use as antitumor agents
EP9401100 1994-04-08

Publications (3)

Publication Number Publication Date
FI946128A FI946128A (fi) 1994-12-28
FI946128A0 true FI946128A0 (fi) 1994-12-28
FI112602B FI112602B (fi) 2003-12-31

Family

ID=10735264

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946128A FI112602B (fi) 1993-05-11 1994-12-28 Menetelmä biologisesti aktiivisten polymeerisitoutuneiden antrasykliinien valmistamiseksi

Country Status (25)

Country Link
US (1) US5571785A (fi)
EP (1) EP0649312B1 (fi)
JP (1) JPH08502519A (fi)
KR (1) KR100330635B1 (fi)
CN (1) CN1098106C (fi)
AT (1) ATE203414T1 (fi)
AU (1) AU671741B2 (fi)
CA (1) CA2136438C (fi)
DE (1) DE69427799T2 (fi)
DK (1) DK0649312T3 (fi)
ES (1) ES2161764T3 (fi)
FI (1) FI112602B (fi)
GB (1) GB9309663D0 (fi)
GR (1) GR3036978T3 (fi)
HU (2) HUT70509A (fi)
IL (1) IL109528A (fi)
MY (1) MY110974A (fi)
NZ (1) NZ265266A (fi)
PL (1) PL175325B1 (fi)
PT (1) PT649312E (fi)
RU (1) RU2145965C1 (fi)
TW (1) TW268015B (fi)
UA (1) UA42695C2 (fi)
WO (1) WO1994026311A1 (fi)
ZA (1) ZA943212B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
GB9721070D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Bioactive derivatives of camptothecin
US20040234497A1 (en) * 2001-05-04 2004-11-25 Yi Luo Hyaluronic acid containing bioconjugates:targeted delivery of anti-cancer drugs to cancer cells
WO2003037915A1 (en) * 2001-10-31 2003-05-08 Biopolymed Inc. Biocompatible polymers including peptide spacer
US20050169883A1 (en) * 2002-05-06 2005-08-04 Prestwich Glenn D. Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
WO2015192124A1 (en) * 2014-06-13 2015-12-17 Trustees Of Tufts College Fap-activated therapeutic agents, and uses related thereto
CN113956325A (zh) 2014-06-13 2022-01-21 塔夫茨大学信托人 Fap激活的治疗剂以及其相关用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
JPS60246400A (ja) * 1984-05-22 1985-12-06 Ajinomoto Co Inc アントラサイクリン系化合物及び制ガン剤
US5169937A (en) * 1986-11-18 1992-12-08 The Scripps Research Institute Method for producing stable glycosylated hemoglobin
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents

Also Published As

Publication number Publication date
CA2136438A1 (en) 1994-11-24
HUT70509A (en) 1995-10-30
AU671741B2 (en) 1996-09-05
IL109528A (en) 1998-08-16
CA2136438C (en) 2004-09-14
GB9309663D0 (en) 1993-06-23
GR3036978T3 (en) 2002-01-31
KR100330635B1 (ko) 2002-09-17
US5571785A (en) 1996-11-05
HU9403811D0 (en) 1995-03-28
CN1098106C (zh) 2003-01-08
DK0649312T3 (da) 2001-11-12
AU6566694A (en) 1994-12-12
IL109528A0 (en) 1994-08-26
HU211538A9 (en) 1995-12-28
WO1994026311A1 (en) 1994-11-24
MY110974A (en) 1999-07-31
RU2145965C1 (ru) 2000-02-27
ATE203414T1 (de) 2001-08-15
FI946128A (fi) 1994-12-28
FI112602B (fi) 2003-12-31
EP0649312B1 (en) 2001-07-25
DE69427799T2 (de) 2002-05-02
PL175325B1 (pl) 1998-12-31
RU94046336A (ru) 1996-10-27
NZ265266A (en) 1996-06-25
PT649312E (pt) 2002-01-30
UA42695C2 (uk) 2001-11-15
ES2161764T3 (es) 2001-12-16
KR950702201A (ko) 1995-06-19
PL306861A1 (en) 1995-04-18
TW268015B (fi) 1996-01-11
ZA943212B (en) 1995-01-18
CN1108454A (zh) 1995-09-13
EP0649312A1 (en) 1995-04-26
DE69427799D1 (de) 2001-08-30
JPH08502519A (ja) 1996-03-19

Similar Documents

Publication Publication Date Title
TW266201B (fi)
DK0673258T3 (da) Polymerbundne camptothecinderivater
CA2456620A1 (en) Compositions comprising photo-labile perfume delivery systems
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
BR0107731A (pt) Lipopeptìdeos de alta pureza, micelas de lipopeptìdeos, processos para preparação dos mesmos, e composições farmacêuticas que os contém
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
AU7585091A (en) Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
FI946128A0 (fi) Biologisesti aktiiviset yhdisteet
CA2127067A1 (fr) Derives d'acide phosphonique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EE200200599A (et) Tsüklipostiiniühend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,ühendi ja preparaadi valmistamine ning selleks vajalik mikroorganism
SE9202218D0 (sv) Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.

MA Patent expired